Alan P. Barton Email & Phone Number

Washington, DC, US

Reston, Virginia, US

North America Payments FP&A

Washington, DC, US

CoStar/LoopNet/Information Services FP&A

Oakland, California, US

Regional FP&A

Washington, DC, US

Cleveland, Ohio, US

• Worked with leadership across Finance, Global Contracting, and Operations and contributed to eight projects matrixed between strategy, finance, and operational advisory
• Modeled eight short-term investment (STIP) options to return £1MM+ on interest for £465MM in debt and equity cash flow injections to Cleveland Clinic London (CCL) buildout
• Built an internal staff budgeting model and supported strategic direction for advisory services on a $5-10MM distressed facility activation proposal with a foreign government hospital system
• Supported annual budget efforts for CCL by consolidating workstream OpEx budgets representing 60MM+ in EBITDA and provided quality assurance through variance analysis
• Analyzed clinical data for patient populations and created a structured proposal to engage a foreign government hospital system for subspecialty referral services and advisory
• Reconfigured and updated the operating cash flow model for the CCL hospital buildout

Science First Partnerships is a bioscience consulting startup using machine learning to provide optimized research fund growth strategies for academic institutions and pharmaceutical companies

New York, NY, US

Rochester, NY, US

• Led an independent project to explore the cost advantages of using 3D printing and PVA hydrogel models ($1.39/model) over commercial products ($1,000+/model) to simulate and train central line placement
• Collected and analyzed preliminary data establishing face, content, and construct validity for models
• Attained CITI certification and successfully generated an Institutional Review Board (IRB) proposal to collect human subject data

Rochester, NY, US

• The overarching project of Dr. Julianna Feola focused on researching the modulating role of human transglutaminase-2 (hTG2) in primary astrocyte apoptosis during times of oxygen-glucose deprivation (OGD). I led an.
• Contributed data suggesting that inhibition of hTG2 transamidation activity with irreversible inhibitor VA4 is protective against OGD in wild-type astrocytes
• Contributed data suggesting that recombinant hTG2 has no mediating extracellular impact on viability after treatment on hTG2-knockout astrocytes during OGD
• Collected and analyzed data using Excel and one-way ANOVA with Tukey’s post-hoc testing to determine significance of VA4 inhibitor treatment on neuron and astrocyte viability

Fort Lauderdale, FL, US

• Work directly with surgeons to document the consenting, pre-operative, and post-operative evaluations for renal and hepatic transplant patients through Allscripts EMR.
• Developed extensive knowledge and experience in multiple Electronic Medical Record (EMR) systems – Epic, Allscripts, and Cerner.

Cleveland, OH, US

• Built and serviced key B2B and B2C relationships for high volume commercial and residential accounts through product expertise, project planning, and cost analysis
• Maintained inventory control, merchandising, and maintenance for $1MM retail store
• Participated in lead generation aimed at building customer relationships and driving store revenue growth by 10% annually
• Learned the fundamentals of income statement (P&L) analysis and inventory expense

Master Of Business Administration (M.B.A.), Finance, Strategy, Healthcare

Master Of Science (M.S.), Physiology

Bachelor Of Arts (B.A.), Philosophy And English